CONCORDBIONSESeptember 06, 2023

Concord Biotech Limited

4,104words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
ol: CONCORDBIO To General Manager, Lis(cid:415)ng Department BSE Limited Phiroze Jeejabhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 543960 Dear Sir/Ma’am, Sub.: Investor Presenta(cid:
20%
3 Manufacturing facilities located at Dholka, Valthera and Limbasi Presence in 70+ Countries 20%+ Market Share by Volume in 5 Molecules ~802 mn Units Formulation Capacity 77 Approved Product
18%
ed APIs Focus on Niche Fermentation API’s with backward integration to KSM Revenue Contribution 18% 11% FY21 82% FY23 89% Portfolio primarily includes immuno- suppressant, Oncology, Anti-Infect
11%
Is Focus on Niche Fermentation API’s with backward integration to KSM Revenue Contribution 18% 11% FY21 82% FY23 89% Portfolio primarily includes immuno- suppressant, Oncology, Anti-Infectives
82%
n Niche Fermentation API’s with backward integration to KSM Revenue Contribution 18% 11% FY21 82% FY23 89% Portfolio primarily includes immuno- suppressant, Oncology, Anti-Infectives & Anti-Fun
89%
mentation API’s with backward integration to KSM Revenue Contribution 18% 11% FY21 82% FY23 89% Portfolio primarily includes immuno- suppressant, Oncology, Anti-Infectives & Anti-Fungal APIs A
75%
in year 2021 • Spread across 596,309 sqm Installed Capacity of 800m3 • • Capacity Utilization at ~75% as of FY23 • Capacity Utilization at ~10% as of FY23 • Capacity Utilization at ~32% as of FY23 1
10%
nstalled Capacity of 800m3 • • Capacity Utilization at ~75% as of FY23 • Capacity Utilization at ~10% as of FY23 • Capacity Utilization at ~32% as of FY23 1,250m3 Total Installed Capacity Zero Disch
32%
ilization at ~75% as of FY23 • Capacity Utilization at ~10% as of FY23 • Capacity Utilization at ~32% as of FY23 1,250m3 Total Installed Capacity Zero Discharge Plants All our facilities have effluen
60.2%
ution from Top 10 customers New Customer Addition / Product addition in existing customers FY20 60.2% 47 FY21 48.2% 48 FY22 47.7% 47 FY23 44.3% 63 Source: Prospectus All Maps used in the pr
48.2%
customers New Customer Addition / Product addition in existing customers FY20 60.2% 47 FY21 48.2% 48 FY22 47.7% 47 FY23 44.3% 63 Source: Prospectus All Maps used in the presentation are no
47.7%
ustomer Addition / Product addition in existing customers FY20 60.2% 47 FY21 48.2% 48 FY22 47.7% 47 FY23 44.3% 63 Source: Prospectus All Maps used in the presentation are not to scale. All d
Advertisement
← All transcriptsCONCORDBIO stock page →